|
MOLST is an acronym for Medical Orders for Life-Sustaining Treatment. The MOLST Program is an initiative to facilitate end-of-life medical decision-making in New York State, Massachusetts, Ohio and Maryland, that involves use of the MOLST form. Most other U.S. states have similar initiatives, such as Physician Orders for Life-Sustaining Treatment. In New York state, the MOLST form is a (New York State Department of Health ) form ((DOH-5003 )). MOLST is for patients such as a terminally ill patient, whether or not treatment is provided.〔(NYCRR § 400.21(b)(6) )〕 == MOLST Program in New York State == The MOLST Program is a New York State initiative that facilitates end-of-life medical decision-making. One goal of the MOLST Program is to ensure that decisions to withhold or withdraw life-sustaining treatment are made in accordance with the patient’s wishes, or, if the patient’s wishes are not reasonably known and cannot with reasonable diligence be ascertained, in accordance with the patient’s best interests.〔 Patricia “Pat” Bomba, MD, has spearheaded the MOLST Program since its inception. Dr. Bomba is a Vice President at Excellus BlueCross BlueShield.〔(Patricia A Bomba MD, FACP )〕 Information about the MOLST Program can be found on the website that Dr. Bomba runs called (www.compassionandsupport.org ). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Medical Orders for Life-Sustaining Treatment」の詳細全文を読む スポンサード リンク
|